Curida Logo
  • About
    • Our Story
    • Our People
    • Locations
    • ESG & Sustainability
    • Careers
  • Services
    • Nasal & Ophthalmic Solutions
    • Biologics & Diagnostic Solutions
    • Pharmacy Formulations
  • Technologies
    • Nasal Spray
    • Blow-Fill-Seal
    • Bottles
    • Multidose
  • Resources
    • View All
    • Articles
    • Blog
    • Events
    • News
  • Contact Us

Resource Listings

Latest From Curida

caleb miller 0Bs3et8FYyg unsplash
Events

Join Curida at PharmaSynergy-OTC, Rome, 10- 11 September

If you’re attending and would like to discuss our Contract Manufacturing capabilities, including nasal sprays, ophthalmics, inhalation, wound...
Read More
A worker using a pippette
Articles

Curida Streamlines Quality Processes with AFRY

To support continued growth, remain future-ready, and align its processes with its sustainability goals, Curida has been working...
Read More
ecovadis logo 2026
News

Curida Achieves Eco Vadis Bronze Award

Over the past year, Curida has completed a double materiality analysis, which provides a solid overview and clear...
Read More
A row of bottles on a conveyor belt
Articles

Controlled Drugs Manufacturing in Europe: Regulation, Nasal Delivery and CDMO Expertise

In this in-depth article, Curida examines how demographic change, rising cancer incidence and evolving clinical practice are driving...
Read More
V4 pdf
News

Curida Announces Strategic Partnership with Rommelag

Curida is proud to announce a new strategic partnership with Rommelag, the global leader in Blow-Fill-Seal (BFS) technology.
Read More
london
Events

Join Curida at PharmaSynergyRx, London: 5-6 February 2026

Read More

Categories

  • View All
  • Articles
  • Blog
  • Events
  • News
Showing 15 of 15
A close up of multiple empty nasal spray bottles
Nasal Sprays & Suspensions
When it comes to nasal spray drug products, the formulation is everything. Most nasal sprays are either solutions...
23.06.2025
A scientist using science equipment.
Tech Transfer in Pharma
Whether you're scaling from R&D to commercial manufacturing or transferring production between sites, a successful tech transfer is...
11.06.2025
IMG 9491 1600x13771 1
Curida, Small Molecules and Biologics CDMO, Secures Equity Investment and Appoints new CEO
Curida has announced a significant growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare private equity...
15.04.2024
  • →
  • 1
  • 2
  • 3
Curida Logo
  • Cookies Policy
  • Privacy Policy
  • Terms & Conditions
  • LinkedIn
© Curida 2026